News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,129 Results
Type
Article (18629)
Company Profile (290)
Press Release (363210)
Section
Business (111599)
Career Advice (437)
Deals (21566)
Drug Delivery (53)
Drug Development (61709)
Employer Resources (52)
FDA (9322)
Job Trends (7632)
News (202315)
Policy (16940)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (1260)
Accelerated approval (2)
Adcomms (15)
Allergies (63)
Alliances (28505)
ALS (69)
Alzheimer's disease (1073)
Antibody-drug conjugate (ADC) (88)
Approvals (9336)
Artificial intelligence (154)
Autoimmune disease (13)
Automation (7)
Bankruptcy (198)
Best Places to Work (6783)
BIOSECURE Act (6)
Biosimilars (47)
Biotechnology (238)
Bladder cancer (53)
Brain cancer (21)
Breast cancer (182)
Cancer (1568)
Cardiovascular disease (121)
Career advice (381)
Career pathing (5)
CAR-T (126)
Cell therapy (350)
Cervical cancer (13)
Clinical research (50380)
Collaboration (594)
Compensation (248)
Complete response letters (17)
COVID-19 (1413)
CRISPR (37)
C-suite (159)
Cystic fibrosis (89)
Data (1628)
Denatured (12)
Depression (34)
Diabetes (172)
Diagnostics (3066)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (18)
Drug discovery (88)
Drug pricing (61)
Drug shortages (17)
Duchenne muscular dystrophy (84)
Earnings (47455)
Editorial (26)
Employer branding (5)
Employer resources (46)
Events (61811)
Executive appointments (454)
FDA (10165)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (547)
Gene editing (91)
Generative AI (14)
Gene therapy (249)
GLP-1 (440)
Government (1948)
Grass and pollen (3)
Guidances (35)
Healthcare (9835)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (88)
Indications (22)
Infectious disease (1500)
Inflammatory bowel disease (119)
Inflation Reduction Act (10)
Influenza (27)
Intellectual property (68)
Interviews (62)
IPO (11473)
IRA (25)
Job creations (1233)
Job search strategy (339)
Kidney cancer (7)
Labor market (9)
Layoffs (224)
Leadership (5)
Legal (2939)
Liver cancer (46)
Lung cancer (218)
Lymphoma (98)
Machine learning (1)
Management (12)
Manufacturing (162)
MASH (51)
Medical device (6237)
Medtech (6239)
Mergers & acquisitions (10522)
Metabolic disorders (475)
Multiple sclerosis (60)
NASH (14)
Neurodegenerative disease (62)
Neuropsychiatric disorders (24)
Neuroscience (1473)
NextGen: Class of 2025 (2955)
Non-profit (1391)
Northern California (1879)
Now hiring (21)
Obesity (253)
Opinion (142)
Ovarian cancer (67)
Pain (59)
Pancreatic cancer (63)
Parkinson's disease (112)
Partnered (7)
Patents (150)
Patient recruitment (79)
Peanut (40)
People (31881)
Pharmaceutical (51)
Pharmacy benefit managers (11)
Phase I (16821)
Phase II (22884)
Phase III (15762)
Pipeline (851)
Podcasts (48)
Policy (60)
Postmarket research (1272)
Preclinical (6853)
Press Release (36)
Prostate cancer (73)
Psychedelics (35)
Radiopharmaceuticals (227)
Rare diseases (310)
Real estate (2122)
Recruiting (19)
Regulatory (13393)
Reports (19)
Research institute (1211)
Resumes & cover letters (58)
Rett syndrome (3)
RNA editing (2)
RSV (22)
Schizophrenia (57)
Series A (107)
Series B (65)
Service/supplier (2)
Sickle cell disease (45)
Southern California (1649)
Special edition (11)
Spinal muscular atrophy (124)
Sponsored (22)
Startups (2246)
State (1)
Stomach cancer (8)
Supply chain (33)
The Weekly (34)
United States (15581)
Vaccines (308)
Venture capitalists (31)
Webinars (8)
Weight loss (152)
Women's health (17)
Worklife (5)
Date
Today (9)
Last 7 days (460)
Last 30 days (1978)
Last 365 days (25907)
2025 (5869)
2024 (27028)
2023 (29940)
2022 (36110)
2021 (38021)
2020 (34000)
2019 (24006)
2018 (17755)
2017 (19632)
2016 (17026)
2015 (20753)
2014 (15145)
2013 (11201)
2012 (11470)
2011 (12023)
2010 (11391)
Location
Africa (294)
Alabama (41)
Alaska (3)
Arizona (94)
Arkansas (8)
Asia (26381)
Australia (5663)
California (4279)
Canada (1511)
China (381)
Colorado (173)
Connecticut (201)
Delaware (100)
Europe (51141)
Florida (584)
Georgia (144)
Idaho (21)
Illinois (276)
India (18)
Indiana (155)
Iowa (1)
Japan (113)
Kansas (65)
Kentucky (8)
Louisiana (7)
Maine (43)
Maryland (560)
Massachusetts (3338)
Michigan (93)
Minnesota (197)
Mississippi (1)
Missouri (44)
Montana (18)
Nebraska (9)
Nevada (41)
New Hampshire (49)
New Jersey (1237)
New Mexico (14)
New York (1183)
North Carolina (692)
North Dakota (5)
Northern California (1879)
Ohio (124)
Oklahoma (9)
Oregon (23)
Pennsylvania (898)
Puerto Rico (5)
Rhode Island (16)
South America (451)
South Carolina (10)
Southern California (1649)
Tennessee (52)
Texas (578)
Utah (91)
Virginia (93)
Washington D.C. (36)
Washington State (429)
West Virginia (2)
Wisconsin (20)
382,129 Results for "bicycle therapeutics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
March 28, 2025
·
9 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 5, 2025
·
2 min read
Press Releases
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025
·
15 min read
Press Releases
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Genetown
Bicycle Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Bicycle Therapeutics plc, a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in June.
June 3, 2024
·
2 min read
Press Releases
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
January 13, 2025
·
10 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2025
February 4, 2025
·
2 min read
Press Releases
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
1 min read
Business
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
9 min read
1 of 38,213
Next
